Study Supporting Earlier Antiretroviral Treatment ‘Not Definitive,’ NEJM Editorial Says

Although the results of a study comparing early and deferred antiretroviral treatment scheduled to be published in the April 30 issue of the New England Journal of Medicine are “striking,” they “cannot be considered definitive evidence that everyone with HIV should start receiving antiretroviral therapy,” Paul Sax and Lindsey Baden of the Division of Infectious Diseases at

Source: Study Supporting Earlier Antiretroviral Treatment ‘Not Definitive,’ NEJM Editorial Says